Skip to content
★ Sign in to follow
BD

Bradley Dickerson

Aurinia Pharmaceuticals Inc.
Total declarations
17
Company
1
▲ Purchases (3 ops.)
€33k
▼ Sales (7 ops.)
€2.2M

Latest filing published 31 Jan 2020 for Aurinia Pharmaceuticals Inc., €805k.

Filing timeline

BuySale
Bradley Dickerson

Insider track record

Disclosed buys
3
Disclosed sells
7
Signal history

Bradley Dickerson: trading record in brief

Bradley Dickerson appears in our data through filings on Aurinia Pharmaceuticals Inc. shares, published by SEC (Form 4). In total, 17 filings cover trades dated from 29 April 2016 to 28 January 2020.

Both buying and selling appear: 3 purchases worth €33k, against 7 sales worth €2.2M. Netting one side against the other leaves €2.2M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 5 option exercises. In 2020 alone, the filings show no purchases and 1 sale.

Half of the purchases are above €11k and half below. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.

The latest filing, published on 31 January 2020, reports an open-market sale of €805k in Aurinia Pharmaceuticals Inc. The latest purchase dates back some time: it was published 2,583 days ago, on 14 October 2019. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Bradley Dickerson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total

17 of 17 declarations